| Analysis | Metabolite Name | Measured Value | Units | level of dysplasia | malignant transformation |
|---|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 2065 | Peak area | HGD | No |
| Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 2765 | Peak area | LGD | No |
| Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 12512 | Peak area | HGD & PDA | yes |
| Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 28263 | Peak area | N/A | No |
| Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 30305 | Peak area | LGD | No |
| Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 37188 | Peak area | HGD & PDA | Yes |
| Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 55436 | Peak area | N/A | No |
| Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 123447 | Peak area | LGD | No |
| Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 157970 | Peak area | N/A | No |
| Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | Peak area | LGD | No |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|